03 September 2024 Imugene: Three Complete Responses in Azer-Cel Allogeneic CD19 CAR T Phase 1b Trial in Blood Cancer (Diffuse Large B-Cell Lymphoma) 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post